News Centre  | Media Releases  | Canadian Media Releases 2005
Novartis Canada Media Releases
2005 Media Releases
12/13/05 New clinical data show dramatic benefits for women with breast cancer
09/29/05 Novartis Major Sponsor for CIBC Run for the Cure
09/21/05 Good news for heart attack survivors
09/15/05 Novartis employees cycle for breast cancer
09/06/05 New treatment for Paget's Disease of the bone
07/14/05 Health Canada grants Priority Review for Exjade for treatment of chronic iron overload due to blood transfusions
05/17/05 Novartis Pharmaceuticals Canada requests Priority Review for Exjade for treatment of chronic iron overload due to blood transfusions
04/08/05 Femara Fills Gap in Treatment of Breast Cancer
03/21/05 New eczema study shows Elidel provides sustained relief
03/01/05 New international survey reveals devastating human cost of eczema
02/28/05 Major study shows Femara* is better than tamoxifen in the adjuvant treatment of early breast cancer
02/23/05 Eczema study investigates relationship with asthma.

2004
2003
2002
2001

Most of Novartis AG's "global" media releases are in English, French, and German. They can be searched by date or key words and there is a rich archive

Novartis Global Media Releases


DISCLAIMER FOR ARCHIVES
The information in our Media Release Archives was factually accurate on the date of publication. This information remains on our website for historical purposes only. Novartis Pharmaceuticals Canada Inc. assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon this information as current or accurate after their publication dates.